Loading…
Based on limited metadata, Mariposa Labs, LLC received an FDA Warning Letter on March 14, 2019, regarding drug products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the issuing office is not specified in the metadata provided. Additional documentation would be needed to identify the particular compliance issues cited.